RXRX Competitors & Alternatives
Compare Recursion Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
RXRX
Main Stock$3.16
Tradestie Score
49
Market Cap
$2.23B
Revenue Growth
-0.6%
Analyst Upside
+110.2%
Top Competitors
224 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$37.72
|
$1.84B | - | 58 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.37
|
$1.81B | - | 64 | Compare |
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$5.73
|
$1.78B | - | 56 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$20.56
|
$1.78B | - | 62 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$17.38
|
$1.74B | - | 61 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$33.28
|
$1.68B | - | 56 | Compare |
|
MNKD
Mannkind Corporation
|
$3.87
|
$1.65B | - | 64 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$38.58
|
$1.63B | - | 67 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.03
|
$1.57B | - | 61 | Compare |
|
VCEL
Vericel Corporation
|
$40.38
|
$1.56B | 93.3 | 57 | Compare |
More RXRX Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2836)
224 stocks in this industry